{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "exchangeTimezoneName": "Europe/Berlin", "exchangeTimezoneShortName": "CEST", "currency": "EUR", "market": "dr_market", "esgPopulated": false, "gmtOffSetMilliseconds": 7200000, "exchange": "FRA", "longName": "Elanix Biotechnologies AG", "shortName": "ELANIX BIOTECHN.AG", "regularMarketPrice": 0.085, "regularMarketChangePercent": 0.0, "messageBoardId": "finmb_4493235", "marketState": "REGULAR", "fiftyTwoWeekHighChangePercent": -0.5952381, "fiftyTwoWeekLow": 0.038, "fiftyTwoWeekHigh": 0.21, "earningsTimestamp": 1498820340, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "fiftyTwoWeekLowChange": 0.047000002, "fiftyTwoWeekLowChangePercent": 1.2368422, "fiftyTwoWeekRange": "0.038 - 0.21", "fiftyTwoWeekHighChange": -0.12499999, "epsTrailingTwelveMonths": -3.54, "sharesOutstanding": 8080900, "bookValue": -0.264, "fiftyDayAverage": 0.08049, "fiftyDayAverageChange": 0.0045100003, "fiftyDayAverageChangePercent": 0.05603181, "twoHundredDayAverage": 0.0986925, "twoHundredDayAverageChange": -0.013692498, "twoHundredDayAverageChangePercent": -0.13873899, "marketCap": 4808135, "priceToBook": -0.3219697, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 946882800000, "priceHint": 4, "regularMarketChange": 0.0, "regularMarketTime": 1683110717, "regularMarketDayHigh": 0.085, "regularMarketDayRange": "0.085 - 0.085", "regularMarketDayLow": 0.085, "regularMarketVolume": 2000, "regularMarketPreviousClose": 0.085, "bid": 0.0005, "ask": 0.0935, "bidSize": 1090, "askSize": 1040, "fullExchangeName": "Frankfurt", "financialCurrency": "EUR", "regularMarketOpen": 0.085, "averageDailyVolume3Month": 1823, "averageDailyVolume10Day": 222, "symbol": "ELN.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "Hanauer Landstrasse 291 B", "city": "Frankfurt am Main", "zip": "60314", "country": "Germany", "website": "https://www.elanixbiotechnologies.ch", "industry": "Drug Manufacturers\u2014Specialty & Generic", "industryDisp": "Drug Manufacturers\u2014Specialty & Generic", "sector": "Healthcare", "longBusinessSummary": "Elanix Biotechnologies AG, a tissue regeneration company, engages in the development and commercialization of products for acute wound care. The company is based in Frankfurt am Main, Germany.", "fullTimeEmployees": 6, "companyOfficers": [{"maxAge": 1, "name": "Prof. Lee-Ann  Laurent-Applegate", "title": "Chief Exec. Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Egon  Minar", "title": "COO & CFO", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "maxAge": 86400}}], "error": null}}